The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Pancreatic Cancer Therapy-Global Market Insights and Sales Trends 2024

Pancreatic Cancer Therapy-Global Market Insights and Sales Trends 2024

Publishing Date : Jan, 2024

License Type :
 

Report Code : 1851980

No of Pages : 103

Ask Your Query

Synopsis

Pancreatic cancer therapy is recommended by clinicians for early detection of cancer. Pancreatic cancer generally diagnosed at a later stage, since the symptoms are not easily detected or diagnosed. Factors such as, chronic inflammation of the pancreas (pancreatitis), diabetes, smoking, and obesity are some of the identified causes of pancreatic cancer.

The global Pancreatic Cancer Therapy market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Pancreatic Cancer Therapy in various end use industries. The expanding demands from the Hospitals, Clinics and Others,, are propelling Pancreatic Cancer Therapy market. Biology, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Chemotherapy segment is estimated at % CAGR for the next seven-year period.

In May 2018, Eli Lilly and Company acquired AMRO BioSciences. AMRO BioSciences is engaged into number of drugs for cancer. The clinical trial explores a drug (pegilodecakin) which is ongoing for the pancreatic cancer. The drug is into phase III of the clinical trials. The acquisition will enhance the therapy products for the Eli Lilly and Company.

Report Objectives

This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Pancreatic Cancer Therapy, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.

Key Features of The Study:

This report provides in-depth analysis of the global Pancreatic Cancer Therapy market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.

This report profiles key players in the global Pancreatic Cancer Therapy market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Pancreatic Cancer Therapy sales data, market share and ranking.

This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.

This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.

Key companies of Pancreatic Cancer Therapy covered in this report include Eli Lilly, Roche, Pfizer, Merck, Celgene, Novartis, Amgen, Teva Pharmaceutical and PharmaCyte Biotech, etc.

The global Pancreatic Cancer Therapy market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.

Market Segmentation

Company Profiles:

  • Eli Lilly
  • Roche
  • Pfizer
  • Merck
  • Celgene
  • Novartis
  • Amgen
  • Teva Pharmaceutical
  • PharmaCyte Biotech
  • Clovis Oncology

Global Pancreatic Cancer Therapy market, by region:

  • North America (U.S., Canada, Mexico)
  • Europe (Germany, France, UK, Italy, etc.)
  • Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
  • South America (Brazil, etc.)
  • Middle East and Africa (Turkey, GCC Countries, Africa, etc.)

Global Pancreatic Cancer Therapy market, Segment by Type:

  • Biology
  • Chemotherapy
  • Targeted Therapy
  • Others

Global Pancreatic Cancer Therapy market, by Application:

  • Hospitals
  • Clinics
  • Others

Core Chapters

Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Pancreatic Cancer Therapy companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion

Index

1 Market Overview of Pancreatic Cancer Therapy
1.1 Pancreatic Cancer Therapy Market Overview
1.1.1 Pancreatic Cancer Therapy Product Scope
1.1.2 Pancreatic Cancer Therapy Market Status and Outlook
1.2 Global Pancreatic Cancer Therapy Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Pancreatic Cancer Therapy Market Size by Region (2018-2029)
1.4 Global Pancreatic Cancer Therapy Historic Market Size by Region (2018-2023)
1.5 Global Pancreatic Cancer Therapy Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Pancreatic Cancer Therapy Market Size (2018-2029)
1.6.1 North America Pancreatic Cancer Therapy Market Size (2018-2029)
1.6.2 Europe Pancreatic Cancer Therapy Market Size (2018-2029)
1.6.3 Asia-Pacific Pancreatic Cancer Therapy Market Size (2018-2029)
1.6.4 Latin America Pancreatic Cancer Therapy Market Size (2018-2029)
1.6.5 Middle East & Africa Pancreatic Cancer Therapy Market Size (2018-2029)
2 Pancreatic Cancer Therapy Market by Type
2.1 Introduction
2.1.1 Biology
2.1.2 Chemotherapy
2.1.3 Targeted Therapy
2.1.4 Others
2.2 Global Pancreatic Cancer Therapy Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Pancreatic Cancer Therapy Historic Market Size by Type (2018-2023)
2.2.2 Global Pancreatic Cancer Therapy Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Pancreatic Cancer Therapy Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Pancreatic Cancer Therapy Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Pancreatic Cancer Therapy Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Pancreatic Cancer Therapy Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Pancreatic Cancer Therapy Revenue Breakdown by Type (2018-2029)
3 Pancreatic Cancer Therapy Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Clinics
3.1.3 Others
3.2 Global Pancreatic Cancer Therapy Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Pancreatic Cancer Therapy Historic Market Size by Application (2018-2023)
3.2.2 Global Pancreatic Cancer Therapy Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Pancreatic Cancer Therapy Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Pancreatic Cancer Therapy Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Pancreatic Cancer Therapy Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Pancreatic Cancer Therapy Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Pancreatic Cancer Therapy Revenue Breakdown by Application (2018-2029)
4 Pancreatic Cancer Therapy Competition Analysis by Players
4.1 Global Pancreatic Cancer Therapy Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Pancreatic Cancer Therapy as of 2022)
4.3 Date of Key Players Enter into Pancreatic Cancer Therapy Market
4.4 Global Top Players Pancreatic Cancer Therapy Headquarters and Area Served
4.5 Key Players Pancreatic Cancer Therapy Product Solution and Service
4.6 Competitive Status
4.6.1 Pancreatic Cancer Therapy Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Eli Lilly
5.1.1 Eli Lilly Profile
5.1.2 Eli Lilly Main Business
5.1.3 Eli Lilly Pancreatic Cancer Therapy Products, Services and Solutions
5.1.4 Eli Lilly Pancreatic Cancer Therapy Revenue (US$ Million) & (2018-2023)
5.1.5 Eli Lilly Recent Developments
5.2 Roche
5.2.1 Roche Profile
5.2.2 Roche Main Business
5.2.3 Roche Pancreatic Cancer Therapy Products, Services and Solutions
5.2.4 Roche Pancreatic Cancer Therapy Revenue (US$ Million) & (2018-2023)
5.2.5 Roche Recent Developments
5.3 Pfizer
5.3.1 Pfizer Profile
5.3.2 Pfizer Main Business
5.3.3 Pfizer Pancreatic Cancer Therapy Products, Services and Solutions
5.3.4 Pfizer Pancreatic Cancer Therapy Revenue (US$ Million) & (2018-2023)
5.3.5 Merck Recent Developments
5.4 Merck
5.4.1 Merck Profile
5.4.2 Merck Main Business
5.4.3 Merck Pancreatic Cancer Therapy Products, Services and Solutions
5.4.4 Merck Pancreatic Cancer Therapy Revenue (US$ Million) & (2018-2023)
5.4.5 Merck Recent Developments
5.5 Celgene
5.5.1 Celgene Profile
5.5.2 Celgene Main Business
5.5.3 Celgene Pancreatic Cancer Therapy Products, Services and Solutions
5.5.4 Celgene Pancreatic Cancer Therapy Revenue (US$ Million) & (2018-2023)
5.5.5 Celgene Recent Developments
5.6 Novartis
5.6.1 Novartis Profile
5.6.2 Novartis Main Business
5.6.3 Novartis Pancreatic Cancer Therapy Products, Services and Solutions
5.6.4 Novartis Pancreatic Cancer Therapy Revenue (US$ Million) & (2018-2023)
5.6.5 Novartis Recent Developments
5.7 Amgen
5.7.1 Amgen Profile
5.7.2 Amgen Main Business
5.7.3 Amgen Pancreatic Cancer Therapy Products, Services and Solutions
5.7.4 Amgen Pancreatic Cancer Therapy Revenue (US$ Million) & (2018-2023)
5.7.5 Amgen Recent Developments
5.8 Teva Pharmaceutical
5.8.1 Teva Pharmaceutical Profile
5.8.2 Teva Pharmaceutical Main Business
5.8.3 Teva Pharmaceutical Pancreatic Cancer Therapy Products, Services and Solutions
5.8.4 Teva Pharmaceutical Pancreatic Cancer Therapy Revenue (US$ Million) & (2018-2023)
5.8.5 Teva Pharmaceutical Recent Developments
5.9 PharmaCyte Biotech
5.9.1 PharmaCyte Biotech Profile
5.9.2 PharmaCyte Biotech Main Business
5.9.3 PharmaCyte Biotech Pancreatic Cancer Therapy Products, Services and Solutions
5.9.4 PharmaCyte Biotech Pancreatic Cancer Therapy Revenue (US$ Million) & (2018-2023)
5.9.5 PharmaCyte Biotech Recent Developments
5.10 Clovis Oncology
5.10.1 Clovis Oncology Profile
5.10.2 Clovis Oncology Main Business
5.10.3 Clovis Oncology Pancreatic Cancer Therapy Products, Services and Solutions
5.10.4 Clovis Oncology Pancreatic Cancer Therapy Revenue (US$ Million) & (2018-2023)
5.10.5 Clovis Oncology Recent Developments
6 North America
6.1 North America Pancreatic Cancer Therapy Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Pancreatic Cancer Therapy Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Pancreatic Cancer Therapy Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Pancreatic Cancer Therapy Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Pancreatic Cancer Therapy Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Pancreatic Cancer Therapy Market Dynamics
11.1 Pancreatic Cancer Therapy Industry Trends
11.2 Pancreatic Cancer Therapy Market Drivers
11.3 Pancreatic Cancer Therapy Market Challenges
11.4 Pancreatic Cancer Therapy Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock